{
  "id": "5a76039b83b0d9ea66000010",
  "type": "summary",
  "question": "What are jakinibs?",
  "ideal_answer": "Jakinibs are Janus kinase (JAK) inhibitors. They are considered a new class of kinase inhibitors in cancer and autoimmune disease. Jakinibs can differ substantially in their selectivity against JAKs.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26994322",
    "http://www.ncbi.nlm.nih.gov/pubmed/22819198"
  ],
  "snippets": [
    {
      "text": "Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22819198",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22819198",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "These receptors rely on Janus family of kinases (Jaks) for signal transduction. Recently the first Jak inhibitor (jakinib) has been approved by the FDA and a second has been recommended for approval. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22819198",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent progress in treating RA has been achieved with janus kinase (JAK) inhibitors (Jakinibs), an orally available disease-modifying anti-rheumatic drug targeting the intracellular kinase JAK and with similar efficacy to biologics.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26994322",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Given these promising findings, Jakinibs are expected to represent the next generation compounds for treating RA, and a number of Jakinibs are currently in clinical trials. Jakinibs can differ substantially in their selectivity against JAKs; tofacitinib and baricitinib target multiple JAKs, whereas the most recently developed Jakinibs target only a single JAK. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26994322",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}